Head-to-Head diabetes drug showdown: new contender takes on established treatment
NCT ID NCT07417306
Summary
This study aims to see if a new drug called HDM1005 works as well or better than an existing drug called mazdutide for controlling blood sugar in adults with type 2 diabetes. It will involve about 912 people whose diabetes is not well-managed with their current metformin-based treatment. Participants will be randomly assigned to receive one of the two drugs for about a year to compare their effectiveness and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.